Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Alnylam Pharmaceuticals
Related studies linked through entity extraction aliases.
A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation
- Status
- COMPLETED
- Phase
- N/A
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Eculizumab to Cemdisiran Switch in aHUS
- Status
- WITHDRAWN
- Phase
- PHASE2
APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate ALN-AGT01 in Patients With Hypertension
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1
- Status
- COMPLETED
- Phase
- PHASE3
Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease
- Status
- TERMINATED
- Phase
- N/A
A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
- Status
- COMPLETED
- Phase
- PHASE3
Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
- Status
- TERMINATED
- Phase
- N/A
A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
- Status
- COMPLETED
- Phase
- PHASE1
An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1
- Status
- COMPLETED
- Phase
- PHASE2